Lei Tang

Lei Tang

Auto-generated profile, based on publicly available information

Lei Tang

Department of Pathology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2024 in Cancer Research
Verified
Journal Article
Closed access
PDF file
FSFeng Shu
Feng Shu
HLHao Liu
Hao Liu
XCXiaohui Chen
Xiaohui Chen
YLYe Liu
Ye Liu
JZJiangli Zhou
Jiangli Zhou
GJGuanmin Jiang
Guanmin Jiang
The widespread use of androgen receptor (AR) signaling inhibitors has led to an increased incidence of AR-negative castration-resistant prostate cancer (CRPC), limiting effective treatment and patient survival. A more comprehensive understanding of the molecular mechanisms supporting AR-negative CRPC could reveal therapeutic vulnerabilities to improve treatment. This study showed that the transcription factor nuclear factor I/B (NFIB) was upregulated in patient with AR-negative CRPC tumors and cell lines and was positively associated with an epithelial-to-mesenchymal transition (EMT) phenotype. Loss of NFIB inhibited EMT and reduced migration of CRPC cells. NFIB directly bound to gene promoters and regulated the transcription of EMT-related factors E-cadherin (CDH1) and vimentin (VIM), independent of other typical EMT-related transcriptional factors. In vivo data further supported the positive role of NFIB in the metastasis of AR-negative CRPC cells. Moreover, N6-methyladenosine (m6A) modification induced NFIB upregulation in AR-negative CRPC. Mechanistically, the m6A levels of mRNA, including NFIB and its E3 ubiquitin ligase TRIM8, were increased in AR-negative CRPC cells. Elevated m6A methylation of NFIB mRNA recruited YTHDF2 to increase mRNA stability and protein expression. Inversely, the m6A modification of TRIM8 mRNA, induced by ALKBH5 downregulation, decreased its translation and expression, which further promoted NFIB protein stability. Overall, this study reveals that upregulation of NFIB, mediated by m6A modification, triggers EMT and metastasis in AR-negative CRPC. Targeting the m6A/NFIB axis is a potential prevention and treatment strategy for AR-negative CRPC metastasis. Significance: NFIB upregulation mediated by increased m6A levels in AR-negative castration-resistant prostate cancer regulates transcription of EMT-related factors to promote metastasis, providing a potential therapeutic target to improve prostate cancer treatment.


14 June 2024
Verified
Other
Open access
FSFeng Shu
Feng Shu
HLHao Liu
Hao Liu
XCXiaohui Chen
Xiaohui Chen
YLYe Liu
Ye Liu
JZJiangli Zhou
Jiangli Zhou
GJGuanmin Jiang
Guanmin Jiang
Data from m6A Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB

14 June 2024
Verified
Other
Open access
FSFeng Shu
Feng Shu
HLHao Liu
Hao Liu
XCXiaohui Chen
Xiaohui Chen
YLYe Liu
Ye Liu
JZJiangli Zhou
Jiangli Zhou
GJGuanmin Jiang
Guanmin Jiang
The sequences of the siRNAs are listed in Supplementary Table S1. And the sequences of the primers, ChIP primers and MeRIP primers used are listed in Supplementary Table S2.

14 June 2024
Verified
Other
Open access
PDF file
FSFeng Shu
Feng Shu
HLHao Liu
Hao Liu
XCXiaohui Chen
Xiaohui Chen
YLYe Liu
Ye Liu
JZJiangli Zhou
Jiangli Zhou
GJGuanmin Jiang
Guanmin Jiang
This PDF contais Supplementary Figures 1-4.

14 June 2024
Verified
Other
Open access
FSFeng Shu
Feng Shu
HLHao Liu
Hao Liu
XCXiaohui Chen
Xiaohui Chen
YLYe Liu
Ye Liu
JZJiangli Zhou
Jiangli Zhou
GJGuanmin Jiang
Guanmin Jiang
The differentially expressed genes in the DU145-shNFIB cells vs DU145-shNC cells was listed in Supplementary Table S3.